Circadian genes  Per1  and  Per2  increase radiosensitivity of glioma  in vivo

Niu Zhanfeng; Li Yanhui; Fei Zhou; Hao Shaocai; Li Guangxing; Xia Hechun

doi:10.18632/oncotarget.3179

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo

Niu Zhanfeng, Li Yanhui, Fei Zhou, Hao Shaocai, Li Guangxing and Xia Hechun _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:9951-9958. https://doi.org/10.18632/oncotarget.3179

Metrics: PDF 3003 views | HTML 3616 views | ?

Abstract

Niu Zhanfeng1,2, Li Yanhui3, Fei Zhou2, Hao Shaocai1, Li Guangxing1, Xia Hechun1,4

1Department of Neurosurgery, The General Hospital of Ningxia Medical University, Yinchuan, China

2Department of Neurosurgery, The Xijing Hospital of The Fourth Miltary Medical University, Xi'an, China

3Graduate School of Ningxia Medical University, Yinchuan, China

4Incubation Base of National Key Laboratory for Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, China

Correspondence to:

Xia Hechun, e-mail: [email protected]

Keywords: Per1, Per2, glioma, radiotherapeutic sensitivity

Received: September 24, 2014 Accepted: January 23, 2015 Published: February 07, 2015

ABSTRACT

Per1 and Per2 play a key role in regulating the circadian rhythm in mammals. We report here that although both genes were expressed with a circadian rhythm in glioma and normal brain tissue in rats, their expression profiles differed in the two types of tissue. In addition, high expression of Per1 and Per2 in glioma tissue was associated with increased sensitivity to x-irradiation. No such sensitizing effect was observed in normal tissue. Our results suggest that Per1 and Per2 expression may increase the efficacy of radiotherapy against glioma by promoting apoptosis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3179

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo

Abstract